688192 迪哲医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(424,057)(650,525)(967,883)(603,373)(492,278)
投资活动产生之现金流量净额(452,033)(38,074)611,190384,556(1,627,300)
筹资活动产生之现金流量净额1,640,908867,013308,249(33,265)1,981,124
汇率变动对现金及现金等价物的影响(223)(2,450)9719,517(6,330)
现金及现金等价物净增加/(减少)764,595175,963(47,473)(242,564)(144,783)
期初现金及现金等价物余额249,89073,927121,399363,964508,747
期末现金及现金等价物余额1,014,485249,89073,927121,399363,964